A pH/ROS dual-responsive system for effective chemoimmunotherapy against melanoma via remodeling tumor immune microenvironment
Acta Pharmaceutica Sinica B · 2024-05 · 14 (5) · 2263-2280
DOI: 10.1016/j.apsb.2023.12.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Pharmaceutica Sinica B, 2024-05. Verfasst von Leilei Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry, West China School of Pharmacy, Sichuan University, Chengdu 61004…. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Chemotherapeutics can induce immunogenic cell death (ICD) in tumor cells, offering new possibilities for cancer therapy. However, the efficiency of the immune response generated is insufficient due to the inhibitory nature of the tumor microenvironment (TME). Here, we developed a pH/reactive oxygen species (ROS) dual-response system to enhance chemoimmunotherapy for melanoma. The system productively accumulated in tumors by specific binding of phenylboronic acid (PBA) to sialic acids (SA). The nanoparticles (NPs) rapidly swelled and released quercetin (QUE) and doxorubicin (DOX) upon the stimulation of tumor microenvironment (TME). The in vitro and in vivo results consistently demonstrated that the NPs improved anti-tumor efficacy and prolonged survival of mice, significantly enhancing the effects of the combination. Our study revealed DOX was an ICD inducer, stimulating immune responses and promoting maturation of dendritic cells (DCs). Additionally, QUE served as a TME regulator by inhibiting the cyclooxygenase-2 (COX2)-prostaglandin E2 (PGE2) axis, which influenced various immune cells, including increasing cytotoxic T cells (CLTs) infiltration, promoting M1 macrophage polarization, and reducing regulatory T cells (Tregs) infiltration. The combination synergistically facilitated chemoimmunotherapy efficacy by remodeling the immunosuppressive microenvironment. This work presents a promising strategy to increase anti-tumor efficiency of chemotherapeutic agents.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry, West China School of Pharmacy, Sichuan University, Chengdu 610041, China.
- Med-X Center for Materials, College of Polymer Science and Engineering, Sichuan University, Chengdu 610065, China.
Zitieren
APA
Wang, L., He, S., Liu, R., Xue, Y., Quan, Y., Shi, R., Yang, X., Lin, Q., Sun, X., Zhang, Z., & Zhang, L. (2024). A pH/ROS dual-responsive system for effective chemoimmunotherapy against melanoma via remodeling tumor immune microenvironment. Acta Pharmaceutica Sinica B, 14(5), 2263-2280. https://doi.org/10.1016/j.apsb.2023.12.001
Vancouver
Wang L, He S, Liu R, Xue Y, Quan Y, Shi R, et al. A pH/ROS dual-responsive system for effective chemoimmunotherapy against melanoma via remodeling tumor immune microenvironment. Acta Pharmaceutica Sinica B. 2024;14(5):2263-2280. doi:10.1016/j.apsb.2023.12.001
BibTeX
@article{Wang2024,
author = {Wang, Leilei and He, Shanshan and Liu, Rong and Xue, Yuan and Quan, Yuan and Shi, Rongying and Yang, Xueying and Lin, Qing and Sun, Xun and Zhang, Zhirong and Zhang, Ling},
title = {A pH/ROS dual-responsive system for effective chemoimmunotherapy against melanoma via remodeling tumor immune microenvironment},
journal = {Acta Pharmaceutica Sinica B},
year = {2024},
volume = {14},
number = {5},
pages = {2263--2280},
doi = {10.1016/j.apsb.2023.12.001}
}
EUVIMED